Ninenovo Publishes Wearable Ring Study on Bilateral Cardiovascular Monitoring
Ninenovo, parent company of RingConn, announced in a press release that a joint team with Professor Cheng Chen's group at Shanghai Jiao Tong University and Mianyang Central Hospital published a study in npj Digital Medicine on bilateral cardiovascular monitoring with wearable rings.
The study analyzed 97,559 valid ring PPG samples from 1,810 participants and included 7,478 paired blood pressure measurements. It examined synchronized photoplethysmography signals from both hands to test whether left and right hand measurements can be treated as interchangeable in wearable monitoring.
Researchers found that synchronized signals from both hands reduced heart rate mean absolute error from 10.65 beats per minute at the population baseline to 3.21 beats per minute. When signal differences stayed below defined thresholds, error fell to 2.59 beats per minute. The heart rate result was consistent across 12 AI model architectures.
Blood pressure results were smaller. Systolic mean absolute error improved from 13.81 to 12.36 millimeters of mercury, and diastolic error improved from 9.27 to 8.21 millimeters of mercury. The study also reported that differences between the two hands may help indicate measurement reliability.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Oct 9 Assort Health and Nextech to Build AI Agent for Ophthalmology Practices Oct 9 PhyPal Relaunches Patient Engagement Platform With Conversational AI Oct 9 Helio Genomics Presents Four HelioLiver Studies on Liver Cancer Detection Oct 8 GenScript and NVIDIA Open Life Sciences AI Startup PitchFest Oct 8 Xtalks Plans Webinar on AI for Antibody Process OptimizationLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
ZBeats Receives FDA Clearance for 14 Day ECG Analysis
AI Model Combines EKG and Blood Tests to Assess Heart Transplant Rejection
QC Healthcare Partners With Sanguina for AI Blood Health Screening
Natura Introduces $99 Interface Ring for AI Agents
CIPRA.ai and Murata Explore AI Wearables for Chronic Care
Daily AI Brief: the AI news that matters, in your inbox.